SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE

Clinical trials for SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE trials appear

Sign up with your email to follow new studies for SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

One-Patient trial tests keytruda for rare ovarian cancer

Disease control Completed

This study tested the drug pembrolizumab (Keytruda) as a follow-up treatment for one patient with a rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). The goal was to see if the drug could help keep the cancer from coming back. Beca…

Matched conditions: SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE

Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE

Get alerted when new SMALL CELL CARCINOMA, HYPERCALCAEMIC TYPE trials appear

One-Patient trial tests keytruda for rare ovarian cancer